LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Collection Device for Sputum Introduced

By LabMedica International staff writers
Posted on 30 Jan 2012
Image: Whole Saliva Collection Device (Photo courtesy of SalivaBio LLC).
Image: Whole Saliva Collection Device (Photo courtesy of SalivaBio LLC).
A new tool has been introduced that makes collecting oral fluids more accurate and much easier.

The collection tube apparatus will enable saliva analytes to be integrated effectively into the clinical laboratory testing process, precisely and hygienically.

The tool, which was developed by the Johns Hopkins University School of Nursing Center for Interdisciplinary Salivary Bioscience Research (CISBR; Baltimore MD, USA), will improve the ease of oral fluid collection, while maintaining the integrity of the biospecimen.

The new Whole Saliva Collection Device is a small, polypropylene collection tube with an integral adapter that comes individually wrapped in a clean, foil pouch with ready-to-go instructions, and is a universal fit with common cryogenic vials. The planned availability for the device is February 2012. Saliva is full of analytes and biomarkers that create a biological journal of exposure to chemicals and disease, and genetic variability. However, the collection of oral fluid has always proved cumbersome, with scientists depending on swabs or collection cups.

Whole saliva is the gold standard when collecting oral fluid for biological testing. Its collection avoids the localized secretions of specific salivary glands making it a more consistent specimen. Whole Saliva can be easily evaluated for volume collected and for salivary flow rate. Free from being compromised by absorbing materials used with other collection methods, Whole Saliva can be assayed for any salivary analyte of interest.

Douglas A. Granger, PhD, director of CISBR and professor of Medicine, Nursing, and Public Health at Johns Hopkins is cofounder of the newly formed commercial company SalivaBio, LLC (Baltimore, MD, USA). Prof. Granger said, "Our studies show that swabs used to collect saliva can retain analytes, cause interference with assays, result in inaccurate estimates of saliva flow rates, and may even produce inaccurate assay results. It's not rocket science; it's a practical solution that will enable saliva analytes to be integrated effectively into basic and clinical studies and consumer applications."

Related Links:

Johns Hopkins University School of Nursing Center
SalivaBio, LLC


Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more